dual alpha-V/beta-1 and alpha-5/beta-1 integrin inhibitors (Pliant Therapeutics/ChemPartner/UCSF)

N/A

Report date: 2025/03/19 08:58:22
NME

Base Information

Drug Namedual alpha-V/beta-1 and alpha-5/beta-1 integrin inhibitors (Pliant Therapeutics/ChemPartner/UCSF)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-5/beta-1 inhibitorsIntegrin alpha-V/beta-1 inhibitors
TargetsIntegrin alpha-5/beta-1Integrin alpha-V/beta-1
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Francisco
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoChemPartner CorpPliant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A